Imunon, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.8M | $-4.2M | $-4.2M | $-3.4M | $-2.7M | $-4.1M | $-4.1M | $-4.8M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $70.0K | $70.0K | $75.1K | $75.1K | $75.0K | $66.7K | $37.2K | $64.3K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $93.3K | $548.6K | $11.5K | $-211.3K | $122.6K | $204.5K | $113.1K | $232.2K |
| Net Cash from Operating Activities | $-3.0M | $-4.0M | $-3.7M | $-4.4M | $-3.0M | $-2.8M | $-4.4M | $-4.1M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $3.6K | $0 | $17.3K | $259.7K | $14.9K | $2.9K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-3.6K | $0 | $-17.3K | $-259.7K | $-14.9K | $-2.9K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.2M | $-1.8K | $7.2M | $5.0M | $4.8M | $105.7K | — | — |
| Net Change in Cash | $7.1M | $-4.0M | $3.5M | $522.2K | $1.9M | $-3.0M | $-4.4M | $5.0M |
| Free Cash Flow | — | — | $-3.7M | $-4.4M | $-3.0M | $-3.1M | $-4.4M | $-4.1M |